NCT00052572 2013-06-24Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative DisordersNational Cancer Institute (NCI)Phase 2 Completed35 enrolled
NCT00006221 2013-02-11BMS-247550 in Treating Patients With Advanced CancersNational Cancer Institute (NCI)Phase 1 Completed54 enrolled